Literature DB >> 9818537

Evaluation of intraocular pressure and cataract formation following the long-term use of nasal corticosteroids.

F Oztürk1, A V Yücetürk, E Kurt, H H Unlü, S S Ilker.   

Abstract

It is possible that corticosteroids administered via nasal spray might reach ocular structures in levels sufficient to provoke an ocular hypertensive response and cause posterior subcapsular cataracts (PSCs) in susceptible individuals. In the present study, 26 patients who had undergone endoscopic sinus surgery were evaluated prospectively with respect to intraocular pressure and PSC formation following the use of nasal steroids for at least three months. Eighteen patients (69%) self-administered 200 micrograms/day of budesonide nasal spray twice daily, and eight patients (31%) self-administered 200 micrograms/day of beclomethasone dipropionate nasal spray twice daily, for a period of three to 19 months (mean 8.8 +/- 3.6 months). Ophthalmologic examination, tonometry, visual field testing and biomicroscopic studies revealed no evidence of ocular hypertension or PSCs during postoperative follow-up. We conclude that intranasal corticosteroids can be used safely for prolonged periods without increasing the risk of ocular hypertension or PSCs.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9818537

Source DB:  PubMed          Journal:  Ear Nose Throat J        ISSN: 0145-5613            Impact factor:   1.697


  9 in total

Review 1.  How to treat allergic rhinitis.

Authors:  N P Lee; E R Arriola
Journal:  West J Med       Date:  1999-07

2.  Intranasal Corticosteroids Do Not Lead to Ocular Changes: A Systematic Review and Meta-analysis.

Authors:  Carla V Valenzuela; James C Liu; Peter M Vila; Laura Simon; Michelle Doering; Judith E C Lieu
Journal:  Laryngoscope       Date:  2018-09-19       Impact factor: 3.325

Review 3.  Ocular toxicity of systemic asthma and allergy treatments.

Authors:  Leonard Bielory
Journal:  Curr Allergy Asthma Rep       Date:  2006-07       Impact factor: 4.806

4.  Impact of Inhaled and Intranasal Corticosteroids Exposure on the Risk of Ocular Hypertension and Glaucoma: A Systematic Review and Meta-Analysis.

Authors:  Anastasiya Vinokurtseva; Matthew Fung; Erica Ai Li; Richard Zhang; James J Armstrong; Cindy M L Hutnik
Journal:  Clin Ophthalmol       Date:  2022-05-30

Review 5.  Adverse Effects of Nonsystemic Steroids (Inhaled, Intranasal, and Cutaneous): a Review of the Literature and Suggested Monitoring Tool.

Authors:  Ratika Gupta; Luz S Fonacier
Journal:  Curr Allergy Asthma Rep       Date:  2016-06       Impact factor: 4.806

Review 6.  The relationship of intranasal steroids to intraocular pressure.

Authors:  Joseph Bergmann; Matthew T Witmer; Charles B Slonim
Journal:  Curr Allergy Asthma Rep       Date:  2009-07       Impact factor: 4.806

7.  Increased risk of open-angle glaucoma following chronic rhinosinusitis: a population-based matched-cohort study.

Authors:  S-D Chung; C-C Lin; J-D Ho; J Ting; H-C Lin; C-C Hu
Journal:  Eye (Lond)       Date:  2013-11-22       Impact factor: 3.775

8.  The effect of long-term use of intranasal steroids on intraocular pressure.

Authors:  Ali Şimşek; Cem Bayraktar; Sedat Doğan; Mehmet Karataş; Yasin Sarıkaya
Journal:  Clin Ophthalmol       Date:  2016-06-10

Review 9.  The Effects of Intranasal, Inhaled and Systemic Glucocorticoids on Intraocular Pressure: A Literature Review.

Authors:  Dries Wijnants; Ingeborg Stalmans; Evelien Vandewalle
Journal:  J Clin Med       Date:  2022-04-03       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.